载万古霉素PLGA-PEG-PLGA温度敏感水凝胶的体外抗菌性能

利用聚乙二醇（PEG 1500）引发乙交酯和D,L-丙交酯开环共聚合制备聚丙交酯乙交酯（PLGA）三嵌段共聚物（PLGA-PEG-PLGA）温敏水凝胶材料,并通过核磁共振氢谱（¹H NMR）确定产物的结构及组成.应用倒置小瓶法测量得到不同浓度下PLGA-PEG-PLGA水凝胶的溶胶-凝胶相变温度为27~32℃.此外,体外降解实验及细胞毒性实验结果表明,质量分数为25%的水凝胶有满意的降解速度及良好的生物相容性.同时,利用紫外-可见光谱分析了载万古霉素水凝胶的体外药物释放行为,结果表明,万古霉素可以持续释放12 d.抗菌实验结果表明,载万古霉素水凝胶具有良好的抗菌效果.表明PLGA-PEG-PLGA三嵌段温敏水凝胶是一种较理想的万古霉素缓释载体,具有良好的临床应用前景.     

水滑石型磁性纳米载药粒子的制备及其体外药物释放性能研究

通过调变镁铁尖晶石的含量, 采用一步共沉淀法制备了一系列具有核壳结构的水滑石型磁性纳米载药粒子, 对其微结构、热稳定性、磁性和药物释放性能进行了系统的研究. 结果表明这种磁性纳米载药粒子是一种具有以镁铁尖晶石为核层、双氯酚酸(Diclofenac, DIC)插层水滑石(DIC-LDH)为壳层的复合纳米粒子, 粒径在90～180 nm之间. 其中壳层DIC-LDH的晶粒尺寸D₁₁₀和层板电荷密度随磁核含量的增大而逐渐减小. 磁性纳米载药粒子的载药量随磁核含量的增大而逐渐减小, 而其比饱和磁化强度则随着磁核含量的增大逐渐增大. 体外释放实验表明, 无外加磁场时, 磁核含量增大, 壳层DIC-LDH粒径减小, 磁性纳米载药粒子药物释放速率逐渐增大|外加1500 G磁场时, 磁核含量增大, 磁致团聚程度增大, 其药物释放速率逐渐减小.     

具有靶向抗癌功能的O-CMC磁性纳米载体系统的制备

首次以O_羧甲基壳聚糖 (O_CMC)为原料 ,制备出具有超顺磁特性的正电性纳米载体 ,并将其与抗癌药物甲氨喋呤 (MTX)结合 ,构建成平均粒径 5 0nm的具有磁靶向抗癌功能的纳米载体系统。该载体在人体血液微循环模型进行的体外靶向定位试验中呈现良好的磁感应性。体外抑瘤试验结果表明 ,该磁性纳米载药体系中MTX保持了较好的抗肿瘤特性。     

PEGMA磁性纳米凝胶的光化学原位合成、表征及载药性能研究

报道了一种应用光化学法一步原位合成具有良好亲水性和生物相容性的PEGMA磁性纳米凝胶的方法．在亲水性Fe3O4纳米粒子水体系中,以甲基丙烯酸聚乙二醇酯（PEGMA）N单体,N,N-亚甲基双丙烯酰胺（MBA）为交联剂,紫外光辐照下原位聚合制备了聚（甲基丙烯酸聚乙二醇酯）磁性纳米凝胶（简称为PEGMA磁性纳米凝胶）,应用傅立叶变换红外光谱（FTIR）和热重分析仪（TGA）对磁性纳米凝胶的表面官能团和组分进行了分析,结果显示经紫外辐照后PEGMA成功包覆在Fe3O4纳米粒子表面,从而制备得到PEGMA磁性纳米凝胶,磁性Fe3O4含量高达53．4％;对磁性纳米凝胶的形貌、粒径、表面Zeta电位及磁学性质等进行了表征,结果显示磁性纳米凝胶形状较规则,具有核-壳结构,干燥状态下平均粒径约为46nm,而湿态下平均水合粒径为68．4nm,表明其外层的水凝胶在水相中具有较强的吸水膨胀能力;磁性纳米凝胶具有超顺磁性,饱和磁化强度为58．6emu／g,在生理pH下,磁性纳米凝胶的表面Zeta电位为-16.3～-17.3mV,能够减少与血红蛋白的吸附作用,可在血液中保持稳定．在其载药性能中发现,PEGMA磁性纳米凝胶对模型药物阿霉素具有良好缓释性能．该超顺磁性纳米凝胶具有高的饱和磁化强度,生理pH下负的表面Zeta电位,以及良好的亲水性和生物相容性等特性,预示着在靶向载药等生物医学领域有着广泛的应用前景．     

单分散磁性纳米粒子靶向药物载体

本文综述了单分散磁性氧化铁纳米粒子的主要制备方法、表面修饰以及在生物医学靶向药物方面的应用研究进展。金属有机前驱体高温热分解法、溶剂热合成法和LSS（liquid-solid-solution）法是目前制备高质量单分散磁性纳米粒子比较有效的手段。通过表面修饰制备出的具有良好水溶性、生物相容性和活性功能基团的磁靶向药物载体将可能实现定位蓄积、高效载药、控制释药和可生物降解等靶向治疗癌症的目的。开发出具有荧光检测、主动靶向识别、高效载药、智能控药释放、无毒副作用和生物相容性于一体的多功能靶向药物载体将是其发展趋势。     

磁性Janus纳米材料的合成及生物性能研究

纳米药物载体在药物输送系统中发挥着极其重要的作用,其中Janus纳米材料因其具有各向异性的特点,能提高药物载体的载药率、靶向性等,成为研究者关注的焦点之一。本实验通过种子异向生长法,以球型磁性Fe_3O_4为内核,在其表面异向生长出棒状介孔二氧化硅,得到球-棒结构的磁性Janus纳米材料(Magnetic Janus Nanomaterials)。在磁性Janus纳米复合材料修饰前后对于布洛芬的搭载及体外释放试验中,发现氨基修饰的磁性Janus纳米复合材料载药率较大且具有缓释的作用。经血液相容性实验发现该材料在200μg·mL~(-1)浓度以下时,溶血率小于5%。     

磁性铁氧化物纳米粒子在药剂学上的应用

磁性铁氧化物纳米粒子（MIONPs）是近几十年发展起来的一种具有磁靶向性的纳米材料,其以良好的磁靶向性、小尺寸效应、生物相容性在生物医学领域具有很好的应用前景,尤其在药剂学领域的应用已经成为一个重要的研究热点。本文在总结近年来国内外有关多功能磁性铁氧化物纳米粒子研究成果的基础上,阐述了各种铁氧化物纳米粒子在药剂学领域的应用,主要是：MIONPs的智能载药靶向控释,MIONPs对特殊药物的靶向负载,MIONPs降低身体的多药耐药性（Multidrug resistance, MDR）,MIONPs加强药物治疗     

羟丙基-β-环糊精磁性复合微粒的合成及作为阿霉素载体的体外释药研究

羟丙基-β-环糊精因具有内部疏水和外部亲水锥形圆筒空腔结构和良好的生物相容性在磁性药物载体方面有潜在应用价值。本研究将羟丙基-β-环糊精修饰在超顺磁性纳米四氧化三铁粒子表面制备磁性复合微粒,用红外光谱,透射电镜,振动磁强计,电感耦合等离子发射等方法对该复合微粒进行了表征,并将其用于抗肿瘤药物阿霉素的体外载药与释药实验研究。结果表明该复合微粒的粒径大小在10-20nm,饱和磁化强度59.9 emu/g,铁含量55.4%。对阿霉素的载药量为87.8 μg/mg。体外释药结果显示载药复合粒子在PBS中1天,4天,10天的累积释药量分别为35.5%, 49.3%, 76.5%,表明该载体具有一定的药物缓释功能。由此可知,羟丙基-β-环糊精磁性复合微粒可作为磁性靶向给药系统的有效载体。     

失水山梨醇脂肪酸酯-聚乙二醇嫁接的聚乙烯醇化磁性药物载体的制备及应用

通过丁二酸酐将失水山梨醇脂肪酸酯(Span80)和聚乙二醇(PEG400)联接在一起,合成了一种新的非离子表面活性剂.然后将其嫁接在聚乙烯醇(PVA)化的Fe3O4磁性粒子上,合成了一种新型靶向药物载体.这种载体兼备了Span80/PEG400类脂囊泡和磁性材料的特点,具有良好的稳定性和靶向作用.将这种新型载体用于两性霉素的包封,包封率可达96.6%,且方法简便.实验过程中采用了FTIR, NMR, XRD和TEM等多种手段进行表征.     

Fe3O4@mMoO3介孔多功能纳米载体的制备及其微波响应药物传递

以氨基功能化的Fe_3O_4纳米颗粒为磁核,结合直接沉淀法和模板法在其表面包覆上介孔MoO_3层,制备磁性-微波热转换性-介孔结构于一体的多功能核-壳结构复合纳米载体Fe_3O_4@mMoO_3,并对其结构、载药及微波控制靶向给药性进行研究。TEM图表明所得的复合纳米载体具有明显的核壳结构,完美的球形,且壳层中有清晰的孔状结构。磁性和微波热转换特性分析表明,该复合载体兼具良好的磁性和微波热转换特性,可实现药物的靶向可控给药。以布洛芬(IBU)为模型药物,对该复合纳米载体的药物负载能力和微波响应可控释放性进行研究,结果表明,在持续微波辐射90 s时IBU的释放率达到90%,远远高于仅搅拌时的释放率。     

用于磁性靶向治疗肺纤维化的聚多巴胺包覆的Fe3O4/甲强龙/环磷酰胺复合超粒子

肺纤维化是一种致命性肺部疾病, 目前临床常规的甲强龙(MPS)联合环磷酰胺(CTX)治疗方法存在明显的不良反应. 基于降低药物毒副作用的目的, 本文设计了一种聚多巴胺(PDA)包覆的Fe₃O₄纳米粒子/甲强龙/环磷酰胺复合超粒子(Fe₃O₄/MPS/CTX@PDA SPs), 提出磁性靶向治疗肺纤维化的思路. 从预制的油溶性Fe₃O₄纳米粒子出发, 通过水包油微乳液模板法制备了Fe₃O₄ 超粒子(SPs), 并在进一步包覆PDA壳层的过程中引入MPS和CTX, 制备了Fe₃O₄/MPS/CTX@PDA SPs, 考察了Fe₃O₄/MPS/CTX@PDA SPs的稳定性、 磁性、 对MPS和CTX的负载及释放, 分析了其生物毒性, 并建立动物模型验证了其磁性靶向功能.     

磁芯负载离子液体凝胶微球的制备、表征及在固定化细胞技术中的应用

选取具有良好生物相容性的壳聚糖(CS)包覆四氧化三铁纳米粒子(Fe₃O₄/CS)作为磁响应材料, 制备了磁芯负载1-丁基-3-甲基咪唑六氟磷酸盐([BMIM]PF₆)凝胶微球; 对Fe₃O₄/CS及磁芯负载离子液体凝胶微球的组成、 结构、 微观形貌和磁性能进行了表征; 将其应用于固定化细胞技术, 在产紫青霉细胞全细胞生物催化甘草酸(GL)合成单葡萄糖醛酸基甘草次酸(GAMG)体系中, 实现了对全细胞生物催化剂和离子液体的快速回收和重复利用. 实验结果表明, 壳聚糖成功包裹Fe₃O₄纳米粒子; Fe₃O₄/CS均匀分布在凝胶微球内部, 并显示出良好的磁性能; 与凝胶微球固定化细胞催化体系相比, 磁芯负载[BMIM]PF₆凝胶微球固定化细胞催化体系中GAMG的产率提高了13.8%; 重复利用实验结果表明, 磁芯负载[BMIM]PF₆凝胶微球固定化产紫青霉细胞在外加磁场的作用下, 易于快速回收, 并且循环再利用9次后相对活性仍保留59.2%.     

磁性介孔纳米粒子的制备及对抗癌药紫杉醇的传输

以十六烷基溴化铵(CTAB)为结构导向剂, 正硅酸乙酯(TEOS)为硅源, 在碱性环境下经过自组装过程对单分散性磁性Fe₃O₄纳米粒子进行包覆, 制备出磁性硅基介孔纳米粒子Fe₃O₄@SiO₂. 结合X射线衍射、 傅里叶变换红外光谱(FTIR)、 透射电子显微镜(TEM)以及氮气吸附-脱附等技术对Fe₃O₄@SiO₂粒子进行表征. 结果表明Fe₃O₄@SiO₂纳米粒子具有球形形貌, 平均直径约为150 nm, 蠕虫状介孔结构, 比表面积为932 m²/g, 孔径为2.5 nm且分布较均匀, 包覆后Fe₃O₄的结构得以保持, 同时材料具有很好的磁响应能力. 以抗癌药紫杉醇(Paelitaxel, TXL)为模型药物进行负载, 实验结果表明, Fe₃O₄@SiO₂对TXL的负载能力为80 mg/g, TXL-Fe₃O₄@SiO₂对TXL的缓释时间持续120 h以上, 累积释放量达到30 mg/g. 通过噻唑蓝比色(MTT)法测量了TXL-Fe₃O₄@SiO₂粒子对体外培养的HeLa细胞的细胞毒性, 与相同浓度的TXL相比, TXL-Fe₃O₄@SiO₂对HeLa细胞的抑制率明显增高.     

Preparation of Functionalized Fe3O4@SiO2 Magnetic Nanoparticles for Monoclonal Antibody Purification

Magnetic Fe₃O₄@SiO₂ nanoparticles with superparamagnetic properties were prepared via a reverse mi-croemulsion method at room temperature. The as-prepared samples were characterized by transmission electron mi-croscopy(TEM), X-ray diffractometry(XRD), and vibrating sample magnetometry(VSM). The Fe₃O₄@SiO₂ nanoparticles were modified by (3-aminopropyl)triethoxysilane(APTES) and subsequently activated by glutaraldehyde(Glu). Protein A was successfully immobilized covalently onto the Glu activated Fe₃O₄@SiO₂ nanoparticles. The adsorption capacity of the nanoparticles was determined on an ultraviolet spectrophotometer(UV) and approximately up to 203 mg/g of protein A could be uniformly immobilized onto the modified Fe₃O₄@SiO₂ magnetic beads. The core-shell of the Fe₃O₄@SiO₂ magnetic beads decorated with protein A showed a good binding capacity for the chime-ric anti-EGFR monoclonal antibody(anti-EGFR mAb). The purity of the anti-EGFR mAb was analyzed by virtue of HPLC. The protein A immobilized affinity beads provided a purity of about 95.4%.     

Controlled Release of Curcumin via Folic Acid Conjugated Magnetic Drug Delivery System

In the paper, folic acid(FA)-mediated and β-cyclodextrin(β-CD) derivatives functionalized magnetic Fe₃O₄ nanoparticles(MNPs) were successfully prepared as drug carriers for the targeted delivery and controlled release of water-insoluble anticancer drug. FA-sulfobutyl ether-β-CD-MNPs(FA-SBE-β-CD-MNPs), FA-hydroxypropyl-β-CD-MNPs(FA-HP-β-CD-MNPs) and FA-carboxymethyl-β-CD-MNPs(FA-CM-β-CD-MNPs) were fabricated, and the loading efficiency and relative entrapment rate of curcumin are 12.04 mg/g, 95.56% for FA-SBE-β-CD-MNPs, 9.6 mg/g, 81.63% for FA-HP-β-CD-MNPs and 7.88 mg/g, 85.28% for FA-CM-β-CD-MNPs, respectively. Meanwhile, at pH=5.0, the optimal release rate of curcumin is about 46.07% for FA-SBE-β-CD-MNPs in 5 h. Cellular uptake indicates that curcumin can be selectively transported to targeting site and released from the internalized carriers. The in vitro cytotoxicity reveals that non-toxic FA-SBE-β-CD-MNPs have excellent biocompatibility on HepG2 cells in the tested concentrations. Therefore, FA-SBE-β-CD-MNPs could provide a promising platform for the targeting delivery of water insoluble anti-cancer drugs for different treatment needs of cancer therapy.     

Fast synthesis of dopamine-coated Fe3O4 nanoparticles through ligand-exchange method

A fast approach was described for the synthesis of water-dispersible monodisperse dopamine-coated Fe₃O₄ nanoparticles（DA-Fe₃O₄） with uniform size and shape via ligand-exchange of oleic acid on Fe₃O₄ using only 2 min.The prepared DA-Fe₃O₄ nanoparticles were characterized by transmission electron microscopy,Fourier transform infrared spectrometry,and vibrating sample magnetometer.The results indicated that the resulting DA-Fe₃O₄ nanoparticles had an average diameter of about 19.2 nm. The magnetic saturation value of the prepared DA-Fe₃O₄ nanoparticles was determined to be 72.87 emu/g,which indicating a well-established superparamagnetic property.     

Recyclable,non-leaching antimicrobial magnetic nanoparticles

Recyclable antimicrobial magnetic nanoparticles, Fe₃O₄@P(St-co-AcQAC), were prepared through surfactantfree seeded emulsion polymerization involving a polymerizable, hydrophobic quaternary ammonium compound (QAC). These antimicrobial magnetic nanoparticles demonstrated excellent antimicrobial activities against both Grampositive and Gram-negative bacteria, and can be reused for multiple times.     

A highly selective magnetic sensor with functionalized Fe/Fe3O4 nanoparticles for detection of Pb2+

A magnetic sensor for detection of Pb~(2+) has been developed based on Fe/Fe_3O_4 nanoparticles modified by3-(3,4-dihydroxyphenyl)propionic acid(DHCA). The carboxyl groups of DHCA have a strong affinity to coordination behavior of Pb~(2+) thus inducing the transformation of Fe/Fe_3O_4 nanoparticles from a dispersed to an aggregated state with a corresponding decrease, then increase in transverse relaxation time(T_2) of the surrounding water protons. Upon addition of the different concentrations of Pb~(2+) to an aq. solution of DHCA functionalized Fe/Fe_3O_4 nanoparticles(DHCA-Fe/Fe_3O_4 NPs)([Fe] = 90 mmol/L), the change of T_2 values display a good linear relationship with the concentration of Pb~(2+) from 40 μmol/L to 100 μmol/L and from 130 μmol/L to 200 μmol/L, respectively. Owing to the especially strong interaction between DHCA and Pb~(2+), DHCA-Fe/Fe_3O_4 NPs exhibited a high selectivity over other metal ions.     

Preparation of Cerium Dioxide Functionalized Magnetic Layered Double Hydroxides for High-efficiency Phosphopeptide Enrichment

In this work, we prepared a material with magnetic nanoparticles (Fe₃O₄) as core, layered double hydroxides(LDHs) as affinity shell, and cerium dioxide(CeO₂) as functional molecules(denoted as Fe₃O₄@LDH-CeO₂). On the basis of combined immobilized metal ion affinity chromatography(IMAC) and metal oxide affinity chromatography(MOAC), Fe₃O₄@LDH-CeO₂ was used to enrich phosphopeptides with high efficiency. The material exhibited high selectivity(α-casein:β-casein:BSA=1:1:5000, mass ratio), high recovery(95.87%), and good reusability of 10 times adsorption- desorption experiments. The feasibility of Fe₃O₄@LDH-CeO₂ was further investigated by extracting phosphopeptides from biological samples(nonfat milk, serum, saliva, and A549 cell lysate).     

High-efficient Isolation of Plant Viral RNA via TMAOH-modified Fe3O4 Magnetic Nanoparticles

Magnetic nanoparticles show great potential in RNA enrichment and separation for rapid detection of viral infection.Fundamental studies on the interaction between RNA and nanoparticles with uniform size and surface property are necessary for designing better adsorbent and optimizing the conditions.In this study,monodispersed superparamagnetic magnetite（Fe3O4） nanoparticles were synthesized by thermal decomposition and modified with tetramethylammonium hydroxide[N（CH3）4OH,TMAOH] that become highly dispersible and stable in water.High-efficiency plant viral RNA adsorption onto TMAOH/Fe3O4 nanoparticles in the extracted solution of plant leaves was demonstrated.The changes of surface charge of TMAOH on the Fe3O4 nanoparticles with pH contribute to the RNA adsorption and elution.Separating viral RNA with magnetic nanoparticles could be a simple,quick andhighly efficient method.